A New Trial Has Been Initiated on BBT-877 for Idiopathic Pulmonary Fibrosis
At the moment, there are two FDA-approved treatment options for people with idiopathic pulmonary fibrosis (IPF). However, given the needs of patients, it is necessary to develop additional therapeutic…